Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Sales (2023 - 2025)

Historic Return on Sales for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to 0.07%.

  • Arcutis Biotherapeutics' Return on Sales rose 10000.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 12700.0%. This contributed to the annual value of 0.71% for FY2024, which is 36900.0% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Return on Sales of 0.07% as of Q3 2025, which was up 10000.0% from 0.19% recorded in Q2 2025.
  • Arcutis Biotherapeutics' Return on Sales' 5-year high stood at 0.07% during Q3 2025, with a 5-year trough of 148.56% in Q3 2022.
  • Moreover, its 4-year median value for Return on Sales was 1.49% (2023), whereas its average is 17.37%.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Return on Sales skyrocketed by 1470700bps in 2023 and then soared by 3300bps in 2025.
  • Over the past 4 years, Arcutis Biotherapeutics' Return on Sales (Quarter) stood at 24.32% in 2022, then soared by 80bps to 4.9% in 2023, then surged by 97bps to 0.15% in 2024, then skyrocketed by 149bps to 0.07% in 2025.
  • Its Return on Sales stands at 0.07% for Q3 2025, versus 0.19% for Q2 2025 and 0.38% for Q1 2025.